| Role of macrophage targeting in the antitumor activity of trabectedin G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ... Cancer cell 23 (2), 249-262, 2013 | 912 | 2013 |
| Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study F Grosso, RL Jones, GD Demetri, IR Judson, JY Blay, A Le Cesne, ... The lancet oncology 8 (7), 595-602, 2007 | 538 | 2007 |
| Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells G Germano, R Frapolli, M Simone, M Tavecchio, E Erba, S Pesce, ... Cancer research 70 (6), 2235-2244, 2010 | 304 | 2010 |
| Frontline extended surgery is associated with improved survival in retroperitoneal low-to intermediate-grade soft tissue sarcomas A Gronchi, R Miceli, C Colombo, S Stacchiotti, P Collini, L Mariani, ... Annals of oncology 23 (4), 1067-1073, 2012 | 251 | 2012 |
| Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution R Sanfilippo, R Miceli, F Grosso, M Fiore, E Puma, E Pennacchioli, ... Annals of surgical oncology 18, 720-725, 2011 | 246 | 2011 |
| Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection A Gronchi, R Miceli, MA Allard, D Callegaro, C Le Péchoux, M Fiore, ... Annals of surgical oncology 22, 1447-1454, 2015 | 190 | 2015 |
| Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network S Stacchiotti, E Palassini, R Sanfilippo, B Vincenzi, MG Arena, ... Annals of oncology 23 (2), 501-508, 2012 | 154 | 2012 |
| Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series F Grosso, R Sanfilippo, E Virdis, C Piovesan, P Collini, P Dileo, C Morosi, ... Annals of Oncology 20 (8), 1439-1444, 2009 | 150 | 2009 |
| Mode of action of trabectedin in myxoid liposarcomas S Di Giandomenico, R Frapolli, E Bello, S Uboldi, SA Licandro, S Marchini, ... Oncogene 33 (44), 5201-5210, 2014 | 143 | 2014 |
| Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma A Gronchi, P Collini, R Miceli, B Valeri, SL Renne, G Dagrada, M Fiore, ... The American journal of surgical pathology 39 (3), 383-393, 2015 | 112 | 2015 |
| Ultra‐rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities S Stacchiotti, AM Frezza, JY Blay, EH Baldini, S Bonvalot, JVMG Bovée, ... Cancer 127 (16), 2934-2942, 2021 | 109 | 2021 |
| Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: a propensity score matching analysis from … L D’Ambrosio, N Touati, JY Blay, G Grignani, R Flippot, AM Czarnecka, ... Cancer 126 (11), 2637-2647, 2020 | 106 | 2020 |
| Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I–II study from the Italian Sarcoma Group A Gronchi, A De Paoli, C Dani, DF Merlo, V Quagliuolo, G Grignani, ... European journal of cancer 50 (4), 784-792, 2014 | 102 | 2014 |
| Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma F Grosso, P Dileo, R Sanfilippo, S Stacchiotti, R Bertulli, C Piovesan, ... European Journal of Cancer 42 (10), 1484-1490, 2006 | 99 | 2006 |
| Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas) R Sanfilippo, RL Jones, JY Blay, A Le Cesne, S Provenzano, G Antoniou, ... Clinical Cancer Research 25 (17), 5295-5300, 2019 | 87 | 2019 |
| Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers R Sanfilippo, F Grosso, RL Jones, S Banerjee, S Pilotti, M D'Incalci, ... Gynecologic oncology 123 (3), 553-556, 2011 | 87 | 2011 |
| Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease … C Coens, WTA van der Graaf, JY Blay, SP Chawla, I Judson, R Sanfilippo, ... Cancer 121 (17), 2933-2941, 2015 | 84 | 2015 |
| ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma A Italiano, A Laurand, A Laroche, P Casali, R Sanfilippo, A Le Cesne, ... Cancer 117 (15), 3445-3456, 2011 | 73 | 2011 |
| Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1 R Dossi, R Frapolli, S Di Giandomenico, L Paracchini, F Bozzi, S Brich, ... International Journal of Cancer 136 (3), 721-729, 2015 | 67 | 2015 |
| Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network R Sanfilippo, P Dileo, JY Blay, A Constantinidou, A Le Cesne, C Benson, ... Anti-Cancer Drugs 26 (6), 678-681, 2015 | 62 | 2015 |
